腹膜后肾上腺区巨大肿瘤分娩式切除24例报告

周伟敏, 黄骥, 涂新华. 腹膜后肾上腺区巨大肿瘤分娩式切除24例报告[J]. 临床泌尿外科杂志, 2024, 39(7): 618-622. doi: 10.13201/j.issn.1001-1420.2024.07.011
引用本文: 周伟敏, 黄骥, 涂新华. 腹膜后肾上腺区巨大肿瘤分娩式切除24例报告[J]. 临床泌尿外科杂志, 2024, 39(7): 618-622. doi: 10.13201/j.issn.1001-1420.2024.07.011
ZHOU Weimin, HUANG Ji, TU Xinhua. Experience of delivery resection surgical policies of giant tumor in retroperitoneal adrenal region: a report of 24 cases[J]. J Clin Urol, 2024, 39(7): 618-622. doi: 10.13201/j.issn.1001-1420.2024.07.011
Citation: ZHOU Weimin, HUANG Ji, TU Xinhua. Experience of delivery resection surgical policies of giant tumor in retroperitoneal adrenal region: a report of 24 cases[J]. J Clin Urol, 2024, 39(7): 618-622. doi: 10.13201/j.issn.1001-1420.2024.07.011

腹膜后肾上腺区巨大肿瘤分娩式切除24例报告

详细信息

Experience of delivery resection surgical policies of giant tumor in retroperitoneal adrenal region: a report of 24 cases

More Information
  • 目的 探索分娩式三步法手术治疗腹膜后肾上腺区巨大肿瘤的经验方法。方法 回顾性分析2013年7月-2020年12月江西省肿瘤医院收治的24例肿瘤长径≥10 cm的腹膜后肾上腺区肿瘤患者临床资料, 手术治疗策略为分娩式三步法。其中男17例, 女7例, 平均年龄(54±17)岁; 肿瘤平均直径(17.6±6.4) cm, 位于左侧11例, 右侧13例。手术治疗策略: 第一步, 打开侧腹膜, 游离肿瘤四周疏松组织, 扩大间隙, 解剖肿瘤与毗邻脏器关系; 第二步, 托举并向外下方牵引肿瘤, 精准处理肿瘤与重要血管、脏器的关系, "分娩"出肿瘤; 第三步, 创面严格止血, 检查临近脏器有无损伤。分析手术时间、出血量、输血量、病理结果, 并进行生存随访。结果 本研究24例手术均顺利完成, 平均手术时间(300±84) min, 平均术中出血量(1 018±965) mL; 完整肿瘤切除的20例, 分块切除、肿瘤有残留的4例; 联合脏器切除15例, 涉及肾12例, 脾脏6例, 胰腺5例, 肠管2例, 胃1例, 胆囊1例, 肝脏1例。病理: 恶性肿瘤20例, 良性肿瘤4例, 其中脂肪肉瘤11例, 炎性肌纤维母细胞瘤3例, 肾上腺皮质癌2例, 绒癌1例, 精原细胞瘤1例, 肾上腺节细胞神经母细胞瘤1例, 肾上腺神经母细胞瘤1例, 副神经节瘤2例, 孤立性纤维肿瘤1例, 嗜铬细胞瘤1例。患者均恢复良好出院。恶性肿瘤中位随访时间50.5个月, 肿瘤1、3、5年总生存率分别为90.0%、74.4%和51.6%。结论 分娩式三步法手术治疗腹膜后肾上腺区巨大肿瘤简单有效, 并发症少, 值得推广。
  • 加载中
  • 图 1  分娩式三步法手术治疗腹膜后神经母细胞瘤示例

    图 2  腹膜后恶性肿瘤Kaplan-Meier生存曲线图

    表 1  手术时间与出血量相关因素分析 例,X±S

    项目 肿瘤直径 肿瘤侵犯
    >15 cm ≤15 cm
    例数 14 10 13 11
    手术时间/min 318±90 288±72 330±961) 258±30
    手术出血量/mL 1136±1 032 855±899 1280±9181) 583±829
    在肿瘤侵犯的评估中,与无肿瘤侵犯比较,1)P < 0.05。
    下载: 导出CSV
  • [1]

    尤爱军. 旋后肩法在肩难产处理中的应用[J]. 中华护理杂志, 2015, 50(11): 1318-1321. doi: 10.3761/j.issn.0254-1769.2015.11.007

    [2]

    Neville A, Herts BR. CT characteristics of primary retroperitoneal neoplasms[J]. Crit Rev Comput Tomogr, 2004, 45(4): 247-270. doi: 10.3109/10408370490506616

    [3]

    罗成华. 腹膜后肿瘤[M]. 北京: 人民卫生出版社, 2013.

    [4]

    Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy[J]. Cancer, 2006, 106(7): 1610-1616. doi: 10.1002/cncr.21761

    [5]

    Munoz P, Bretcha-Boix P, Artigas V, et al. Surgical principles of primary retroperitoneal sarcoma in the era of personalized treatment: a review of the frontline extended surgery[J]. Cancers, 2022, 14(17): 4091. doi: 10.3390/cancers14174091

    [6]

    Callegaro D, Raut CP, Ng D, et al. Has the outcome for patients who undergo resection of primary retroperitoneal sarcoma changed over time?A study of time trends during the past 15years[J]. Ann Surg Oncol, 2021, 28(3): 1700-1709. doi: 10.1245/s10434-020-09065-6

    [7]

    Gronchi A, Vullo SL, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients[J]. J Clin Oncol, 2009, 27(1): 24-30. doi: 10.1200/JCO.2008.17.8871

    [8]

    龚宇, 宋波, 李为兵, 等. 腹膜后巨大肿瘤的手术切除[J]. 临床泌尿外科杂志, 2004, 19(10): 580-582, 641. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW200410001.htm

    [9]

    Callegaro D, Miceli R, Brunelli C, et al. Long-term morbidity after multivisceral resection for retroperitoneal sarcoma[J]. Br J Surg, 2015, 102(9): 1079-1087. doi: 10.1002/bjs.9829

    [10]

    Fiore M, Baia M, Conti L, et al. Residual adrenal function after multivisceral resection with adrenalectomy in adult patients[J]. JAMA Surg, 2022, 157(5): 415-423. doi: 10.1001/jamasurg.2021.7588

    [11]

    Gorji L, Nikahd M, Onuma A, et al. Comparing multivisceral resection with tumor-only resection of liposarcoma using the win ratio[J]. Ann Surg Oncol, 2024, 31(5): 3389-3396. doi: 10.1245/s10434-024-14985-8

    [12]

    Guo Q, Zhao JC, Du XJ, et al. Survival outcomes of surgery for retroperitoneal sarcomas: a systematic review and meta-analysis[J]. PLoS One, 2022, 17(7): e0272044. doi: 10.1371/journal.pone.0272044

    [13]

    Gladdy RA, Gupta A, Catton CN. Retroperitoneal sarcoma: fact, opinion, and controversy[J]. Surg Oncol Clin N Am, 2016, 25(4): 697-711. doi: 10.1016/j.soc.2016.05.003

    [14]

    García-Aceituno L, Villarreal-Garza C, Perfecto M, et al. Retroperitoneal soft tissue sarcomas: experience at a single institution in Mexico[J]. World J Surg, 2010, 34(7): 1511-1516. doi: 10.1007/s00268-010-0473-9

  • 加载中

(2)

(1)

计量
  • 文章访问数:  732
  • PDF下载数:  443
  • 施引文献:  0
出版历程
收稿日期:  2023-08-23
刊出日期:  2024-07-06

目录